Loading stock data…
QDEL
$16.05-0.53 (-3.20%)
Market ClosedLast close Jul 24
QuidelOrtho Corporation provides diagnostic testing solutions.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
QuidelOrtho Corporation in the Healthcare sector is trading at $16.05 with a market capitalization of $982M. Wall Street consensus targets $20.50 (4 analysts), implying a +27.7% move over the next 12 months. The stock is currently 55% below its 52-week high of $35.58, remaining 24.0% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +27.7% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 34) — potential for technical mean-reversion
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $619.80M↓ | $723.60M↑ | $699.90M↑ | $613.90M↓ | $692.80M |
| Gross Profit | $263.80M↓ | $320.40M↓ | $335.60M↑ | $274.90M↓ | $343.30M |
| Operating Income | -$27.40M↑ | -$37.30M↓ | $45.20M↑ | -$1.80M↓ | $48.70M |
| Net Income | -$91.80M↑ | -$130.70M↑ | -$733.00M↓ | -$255.40M↓ | -$12.70M |
Peer Comparison
JNJUNHPFE
Fundamentals
QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$981.61M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-65.40%
Volume
Today's trading volume
877,368
Recent News
3 Reasons to Sell QDEL and 1 Stock to Buy Instead
What a brutal six months it’s been for QuidelOrtho. The stock has dropped 40.6% and now trades at $16.68, rattling many shareholders. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
Reasons to Add QuidelOrtho Stock in Your Portfolio for Now
QDEL's strong portfolio, cost-saving progress and mixed first-quarter results support growth, though respiratory reliance remains a risk.
3 Healthcare Stocks We Approach with Caution
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not only realized strong financial performance but also propelled the broader industry’s returns as healthcare stocks have gained 10.2% over the past six months while the S&P 500 was up 7.7%.
Zacks Industry Outlook Highlights Terumo, QuidelOrtho, Lumexa Imaging and Brainsway
Terumo stands out as medical products companies navigate cost pressures with innovation, pricing actions and demand for advanced diagnostics supporting growth.
Spotting Winners: QuidelOrtho (NASDAQ:QDEL) And Healthcare Equipment and Supplies Stocks In Q1
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at QuidelOrtho (NASDAQ:QDEL) and the best and worst performers in the healthcare equipment and supplies industry.